COX-2 Inhibitor Found To Help Prevent Gastric Cancer

Published: 2004-12-07 06:59:00

Updated: 2004-12-07 06:59:00

The Korea Food and Drug Administration (KFDA) announced December 3rd on its discovery of additional efficacy of COX-2 (cyclooxygenase-2) inhibitor, which is a type of non-steroidal anti-inflammatory drugs (NSAIDs) for treatment of arthritis, in prevention of gastric cancer of Helicobacter pylori origin.

The research findings indicate that the enzyme, COX-2, begins to appear in tissues that a...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.